Coronavirus: EU reserves 300 mln doses of potential Sanofi COVID-19 vaccine
The EU announced on Friday that it had struck a deal with French pharmaceutical giant Sanofi for 300 million doses of a potential coronavirus vaccine.
The European Commission, the bloc’s executive arm which negotiated the agreement, said it would allow all 27 member countries to purchase the vaccine once it was proven to be safe and effective.
For more coronavirus news, visit our dedicated page.
In a related development, the US government will pay $2.1 billion to Sanofi and GlaxoSmithKline for COVID-19 vaccines to cover 50 million people and to underwrite the drug makers’ testing and manufacturing, the companies said on Friday.
For all the latest headlines follow our Google News channel online or via the app.
Read more:
Coronavirus: Chinese-backed hackers targeted COVID-19 vaccine firm Moderna
Children under five carry 10-100 higher levels of coronavirus in their noses: Study
Also Read
-
Coronavirus: EU countries close in on $2.1 trillion budget and COVID-19 recovery fund
Weary European Union leaders finally were closing in on an unprecedented 1.82 trillion euro ($2.1 trillion) budget and coronavirus recovery fund early ... Coronavirus -
Spain welcomes $824 bln EU coronavirus fund plan as good basis for talks
The Spanish government said on Wednesday the European Union’s proposal for a 750 billion euro ($824 bln) coronavirus recovery fund would serve as a ... Coronavirus -
French coronavirus drugmaker Sanofi pushes for COVID-19 vaccine approval
French drugmaker Sanofi expects to win approval for a COVID-19 vaccine in the first half of next year as it strengthens a pact with Translate Bio Inc. ... Coronavirus
